Results

Total Results: 2,146 records

Showing results for "factor".

81. Stroke-Atrial-Fibrillation Executive (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/stroke-atrial-fibrillation_executive.pdf
    August 01, 2013 - has been identified by the Stroke Risk in Atrial Fibrillation Working Group as the strongest risk factor … IIa (thrombin) inhibitor dabigatran26 • ROCKET AF (Rivaroxaban Once-daily, oral, direct factor Xa … • A factor IIa inhibitor (dabigatran) at a 110 mg dose is noninferior to warfarin for the composite … Factor IIa Inhibitor (Dabigatran 110 mg) vs. … For this evidence gap, we suggest focusing specifically on the comparative effectiveness of factor

82. Interventions To Prevent Age-Related Cognitive Decline, Mild Cognitive Impairment, and Clinical Alzheimer’s-Type Dementia (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/cognitive-decline_executive.pdf
    March 01, 2017 - If changing a putative risk factor changes the cognitive course, it will be seen as more salient. … including nutrition, physical activity, cognitive training, social activity, and/or vascular risk factor … seeking to slow or prevent age- related cognitive decline, MCI, and CATD may have more than one risk factor … For example, obesity is a risk factor of concern but it can be studied only in the context of prevention … addressing nutrition, physical activity, cognitive training, social activity, and/or vascular risk factor

83. Interventions To Prevent Age-Related Cognitive Decline, Mild Cognitive Impairment, and Clinical Alzheimer’s-Type Dementia (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cognitive-decline_executive.pdf
    March 01, 2017 - If changing a putative risk factor changes the cognitive course, it will be seen as more salient. … including nutrition, physical activity, cognitive training, social activity, and/or vascular risk factor … seeking to slow or prevent age- related cognitive decline, MCI, and CATD may have more than one risk factor … For example, obesity is a risk factor of concern but it can be studied only in the context of prevention … addressing nutrition, physical activity, cognitive training, social activity, and/or vascular risk factor

84. Microsoft Word - cognitive-decline-protocol-160322.docx (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/cognitive-decline_research-protocol.pdf
    March 22, 2016 - addressing nutrition, physical activity, cognitive training, social activity, and/or vascular risk factor … The etiology may involve more than one risk factor and interventions may have several components. … interventions for preventing dementia have looked at only the one-to-one relationship with a single risk factor … characteristics (i.e., age, sex, race/ethnicity, family history, education, socio-economic status, risk factor … characteristics (i.e., age, sex, race/ethnicity, family history, education, socio-economic status, risk factor

85. Data Points #8: Utilization of antihypertensive drug classes among Medicare beneficiaries with hypertension, 2007 to 2009 | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/products/hypertension-drugs-utilization/research
    November 16, 2011 - Hypertension is a risk factor for numerous pathologic conditions, including heart attack, heart failure

86. Executive Summary: Healthcare Industry Waste and Use of Life (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/lifecycle-assessment-executive-summary.pdf
    September 01, 2023 - To address gaps, further research should include emission factor databases specific to healthcare, a … Development of healthcare specific emission factor databases would address the gap in available data

87. Juvenile-Arthritis-Dmards Surveillance (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/juvenile-arthritis-dmards_surveillance.pdf
    March 14, 2013 - Tumour necrosis factor (TNF)-blocking agents in juvenile psoriatic arthritis: are they effective? … Tumor necrosis factor-blocking agents for children with enthesitis-related arthritis-- data from the … Experiences with tumour necrosis factor- {alpha} inhibitors in patients with juvenile idiopathic arthritis … Subjects Primary Outcome Duration Findings Nakatani, 201113 Case report, methotrexate 1 Rheumatoid factor … RCT of etanercept+methotrexate (MTX)+prednisolone (arm 1) vs methotrexate (arm 2) 85 Rheumatoid factor

88. Juvenile-Arthritis-Dmards Surveillance (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/juvenile-arthritis-dmards_surveillance.pdf
    March 14, 2013 - Tumour necrosis factor (TNF)-blocking agents in juvenile psoriatic arthritis: are they effective? … Tumor necrosis factor-blocking agents for children with enthesitis-related arthritis-- data from the … Experiences with tumour necrosis factor- {alpha} inhibitors in patients with juvenile idiopathic arthritis … Subjects Primary Outcome Duration Findings Nakatani, 201113 Case report, methotrexate 1 Rheumatoid factor … RCT of etanercept+methotrexate (MTX)+prednisolone (arm 1) vs methotrexate (arm 2) 85 Rheumatoid factor

89. Maternal Morbidity and Mortality (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/mmm-draft-protocol-amendment.pdf
    February 02, 2022 - Indigenous, People of Color (BIPOC) individuals.13 Important to recognize is that race itself is not a risk factor … We will use the ROBINS-E tool, which is designed specifically to address risk factor research.32, 33 … when 1) at least two studies with sufficiently similar designs and populations examined the same risk factor … identify people followed in a study to help understand who may be similarly be subject to the risk factor … or logistic regression or "near miss").ti,ab,kw. 775160 10 (risk* adj3 (assess* or factor

90. Evidence-based Practice Center Systematic Review Protocol (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/juvenile-arthritis-dmards_research-protocol.pdf
    March 09, 2010 - : affects five or more joints during the first 6 months of disease; is subclassified as rheumatoid factor-negative … and rheumatoid factor-positive disease, the latter of which may be associated with more destructive … nephrotoxicity; hepatotoxicity D-Penicillamine Depen Cuprimine Unknown (may lower IgM rheumatoid factor … sensitivity analyses include: study quality, including the quality of the measurement of exposure to the factor … Settings RCTs Randomized Controlled Trials TEP Technical Expert Panel TNF Tumor Necrosis Factor

91. Topic Brief: Sensory Processing Disorders and Fibromyalgia (pdf file)
    effectivehealthcare.ahrq.gov/system/files/docs/topic-brief-sensory-processing-disorders-fibromyalgia.pdf
    March 27, 2021 - research is needed. 2 • Psychological trauma has been evaluated as a potential precipitating factor

92. Vte-Prophyalaxis Executive (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/vte-prophyalaxis_executive.pdf
    May 01, 2013 - Rivaroxaban was included; it is an oral factor Xa inhibitor that the FDA approved in July 2011 for … direct thrombin inhibitors) • IVC filters • Mechanical devices • Pharmacologic (UFH LMWHs, factor … Xa inhibitors, direct thrombin inhibitors) • Pharmacologic (UFH, LMWHs, factor Xa inhibitors, … direct thrombin inhibitors) • Mechanical devices IVC filters • Pharmacologic (UFH LMWHs, factor … studies, studies that used active controls, and uncontrolled studies • Low-dose UFH, LMWHs, factor

93. Methods Guide for Medical Test Reviews Chapter 6 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-tests-applicability_methods.pdf
    July 01, 2012 - Decisions should be based on whether there is evidence that a particular contextual factor is expected … assessing the accuracy of cardiac MRI for detecting atherosclerosis, slice thickness is a relevant factor … Preventive Care Over Time Routine use of a medical test as a screening test might be considered an indirect factor … In some cases, failing to consider a particular factor may have been an oversight; in retrospect, the … importance of that factor on the applicability of test results may be physiologically sensible and

94. Evaluation and Treatment of Tinnitus: A Comparative Effectiveness Review | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/products/tinnitus/research-protocol
    February 22, 2012 - traditional Chinese medicinal treatment used to increase blood flow, inhibit the platelet-activating factor … control for a second important factor.) … control for a second important factor.) 1) Assessment of outcome a) independent blind assessment … The prognostic factor measure and method are adequately valid and reliable to limit misclassification … Appropriate methods are used if imputation is used for missing prognostic factor 4.

95. Stroke Prevention in Atrial Fibrillation Patients: A Systematic Review Update | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/products/stroke-afib-update/research-protocol
    July 07, 2017 - patients with a score ≥2, and it should be considered for patients with a score of 1 (i.e., with one risk factor … patients with non-valvular AF: dabigatran (thrombin inhibitor), apixaban, rivaroxaban, and edoxaban (all factor … Newer anticoagulants (direct oral anticoagulants [DOACs]) Direct thrombin Inh-DTI: Dabigatran Factor … Inhibitors"[Mesh] OR "Anticoagulants"[Pharmacological Action] OR "Factor Xa Inhibitors"[Pharmacological … thrombin inhibitors"[tiab] OR antithrombin[tiab] OR antithrombins[tiab] OR antithrombotic[tiab] OR "factor

96. Pressure Ulcer Risk Assessment and Prevention: A Comparative Effectiveness Review | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/products/pressure-ulcer-prevention/research-protocol
    January 10, 2012 - Sensitivity and Specificity"/ or "Reproducibility of Results"/ or "Severity of Illness Index"/ or (risk adj2 (factor … Curve/ 11 "Sensitivity and Specificity"/ 12 "Reproducibility of Results"/ 13 or/6-12 14 (risk adj2 (factor … Curve/ 11 "Sensitivity and Specificity"/ 12 "Reproducibility of Results"/ 13 or/6-12 14 (risk adj2 (factor … Reproducibility of Results") S13 (MH "ROC Curve") S14 S7 or S8 or S9 or S10 or S11 or S12 or S13 S15 "risk factor … Curve/ 11 "Sensitivity and Specificity"/ 12 "Reproducibility of Results"/ 13 or/6-12 14 (risk adj2 (factor

97. Evidence-based Practice Center Systematic Review Protocol (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/pressure-ulcer-prevention_research-protocol.pdf
    January 10, 2012 - and Specificity"/ or "Reproducibility of Results"/ or "Severity of Illness Index"/ or (risk adj2 (factor … Sensitivity and Specificity"/ 12 "Reproducibility of Results"/ 13 or/6-12 14 (risk adj2 (factor … Sensitivity and Specificity"/ 12 "Reproducibility of Results"/ 13 or/6-12 14 (risk adj2 (factor … Results") S13 (MH "ROC Curve") S14 S7 or S8 or S9 or S10 or S11 or S12 or S13 S15 "risk factor … Sensitivity and Specificity"/ 12 "Reproducibility of Results"/ 13 or/6-12 14 (risk adj2 (factor

98. PULMONARY with "Discussions" in Exec Summary (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pulmonary-horizon-scan-high-impact-1412.pdf
    October 01, 2015 - tyrosine kinase inhibitor that targets the intracellular signaling of multiple proangiogenic growth factor … receptors purportedly involved in the pathogenesis of IPF, including vascular endothelial growth factor … receptor 2 (VEGFR2), fibroblast growth factor receptor (FGFR), and platelet-derived growth factor … receptor kinase activity of vascular endothelial growth factor receptor 2 (VEGFR2), fibroblast growth … factor receptor (FGFR), and platelet-derived growth factor receptor (PDGFR).

99. Safety of Vaccines Used for Routine Immunization in the United States | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/products/vaccine-safety/research
    July 01, 2014 - of post-licensure analyses: case-control studies, self-controlled case series, and multivariate risk factor

100. Comparing the Effectiveness of Treatment Strategies for Primary Open-Angle Glaucoma | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/glaucoma/abstract
     November 09, 2011 - legal blindness in the country. 3,4 For primary open-angle glaucoma (POAG), race is an important risk factor